REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for tough blood cancers in early trial
Disease control CompletedThis early-phase study tested an experimental oral drug called LP-108, given alone or with another drug (azacitidine), in 32 adults whose myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia had returned or stopped responding to treatment. The mai…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New hope for kids with tough leukemia: drug combo shows promise
Disease control CompletedThis early-phase study tested a drug called palbociclib combined with standard chemotherapy in children whose acute lymphoblastic leukemia (ALL) had returned or stopped responding to treatment. Only 2 children took part, and the main goal was to find a safe dose and check for sid…
Matched conditions: REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated May 11, 2026 20:47 UTC